Related references
Note: Only part of the references are listed.From Whole-Brain Radiotherapy to Immunotherapy: A Multidisciplinary Approach for Patients with Brain Metastases from NSCLC
Maria Protopapa et al.
JOURNAL OF ONCOLOGY (2019)
Novel Multiple Sclerosis Drugs in the Pipeline
Floriana De Angelis et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Erenumab in chronic migraine Patient-reported outcomes in a randomized double-blind study
Richard B. Lipton et al.
NEUROLOGY (2019)
Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer
Alessandro Parodi et al.
PHARMACEUTICS (2019)
Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries
Lena Ohlsson et al.
CEPHALALGIA (2019)
Engineered antibodies: new possibilities for brain PET?
Dag Sehlin et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Approaches to CNS Drug Delivery with a Focus on Transporter-Mediated Transcytosis
Rana Abdul Razzak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Beyond the Barrier: Targeted Radionuclide Therapy in Brain Tumors and Metastases
Janik Puttemans et al.
PHARMACEUTICS (2019)
Brain metastasis as exclusion criteria in clinical trials involving extensive-stage small cell lung cancer
Andy Wang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Immune Microenvironment of Brain Metastases-Are Microglia and Other Brain Macrophages Little Helpers?
Hua You et al.
FRONTIERS IN IMMUNOLOGY (2019)
The evolving role of trastuzumab emtansine (T-DM1) in HER2-positive breast cancer with brain metastases
Rongrong Dong et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Antibodies to watch in 2019
Helene Kaplon et al.
MABS (2019)
Transcytosis to Cross the Blood Brain Barrier, New Advancements and Challenges
Victor M. Pulgar
FRONTIERS IN NEUROSCIENCE (2019)
Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics
Wei Tang et al.
CHEMICAL SOCIETY REVIEWS (2019)
David vs. Goliath: The Structure, Function, and Clinical Prospects of Antibody Fragments
Adam Bates et al.
ANTIBODIES (2019)
Alzheimer's disease drug development pipeline: 2019
Jeffrey Cummings et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
Targeting Brain-Adaptive Cancer Stem Cells Prohibits Brain Metastatic Colonization of Triple-Negative Breast Cancer
Ding Ren et al.
CANCER RESEARCH (2018)
Blood Brain Barrier: A Review of Its Anatomy and Physiology in Health and Disease
Yousra Sharif et al.
CLINICAL ANATOMY (2018)
Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain?
Sheheryar Kabraji et al.
CLINICAL CANCER RESEARCH (2018)
Peptide Mediated Brain Delivery of Nano- and Submicroparticles: A Synergistic Approach
Mark McCully et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group
D. Ross Camidge et al.
LANCET ONCOLOGY (2018)
Metastatic niche functions and therapeutic opportunities
Toni Celia-Terrassa et al.
NATURE CELL BIOLOGY (2018)
Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting
Neja Samec et al.
Oncotarget (2018)
Current Strategies for Brain Drug Delivery
Xiaowei Dong
THERANOSTICS (2018)
Mechanisms and Therapy for Cancer Metastasis to the Brain
Federica Franchino et al.
FRONTIERS IN ONCOLOGY (2018)
Overcoming the Blood-Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Denzil Furtado et al.
ADVANCED MATERIALS (2018)
Cell penetrating peptides: A concise review with emphasis on biomedical applications
Hossein Derakhshankhah et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo Gonzalez et al.
GENES & DEVELOPMENT (2018)
Blood-Brain Delivery Methods Using Nanotechnology
Daniel Mihai Teleanu et al.
PHARMACEUTICS (2018)
Possible strategies to cross the blood-brain barrier
Cinzia M. Bellettato et al.
ITALIAN JOURNAL OF PEDIATRICS (2018)
Membrane Active Peptides and Their Biophysical Characterization
Fatma Gizem Avci et al.
BIOMOLECULES (2018)
Peptibodies: An elegant solution for a long-standing problem
Marco Cavaco et al.
PEPTIDE SCIENCE (2018)
Routes for Drug Translocation Across the Blood-Brain Barrier: Exploiting Peptides as Delivery Vectors
Mie Kristensen et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study
Daniel N. Cagney et al.
NEURO-ONCOLOGY (2017)
Targeting blood-brain-barrier transcytosis - perspectives for drug delivery
Imre Mager et al.
NEUROPHARMACOLOGY (2017)
A Controlled Trial of Erenumab for Episodic Migraine
Peter J. Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Targeted therapy of brain metastases: latest evidence and clinical implications
Rodica Di Lorenzo et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2017)
Antibody or Antibody Fragments: Implications for Molecular Imaging and Targeted Therapy of Solid Tumors
Katerina T. Xenaki et al.
FRONTIERS IN IMMUNOLOGY (2017)
Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy
Yaozhong Hu et al.
FRONTIERS IN IMMUNOLOGY (2017)
Emerging treatment paradigms for brain metastasis in non-small-cell lung cancer: an overview of the current landscape and challenges ahead
D. Ulahannan et al.
ANNALS OF ONCOLOGY (2017)
Interactions Between Therapeutic Proteins and Small Molecules: The Shared Role of Perpetrators and Victims
M. Cavaco et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
The use of natalizumab for multiple sclerosis
Rachel Brandstadter et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2017)
Novel Peptides Derived from Dengue Virus Capsid Protein Translocate Reversibly the Blood-Brain Barrier through a Receptor-Free Mechanism
Vera Neves et al.
ACS CHEMICAL BIOLOGY (2017)
Therapeutic monoclonal antibodies and derivatives: Historical perspectives and future directions
Kyla R. Rodgers et al.
BIOTECHNOLOGY ADVANCES (2016)
Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery
Benjami Oller-Salvia et al.
CHEMICAL SOCIETY REVIEWS (2016)
Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases
Claudia Saraiva et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Metastatic colonization by circulating tumour cells
Joan Massague et al.
NATURE (2016)
Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies
Y. Joy Yu Zuchero et al.
NEURON (2016)
Emerging therapeutic targets in metastatic progression: A focus on breast cancer
Zhuo Li et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Antibody Approaches To Treat Brain Diseases
Vera Neves et al.
TRENDS IN BIOTECHNOLOGY (2016)
Strategies for transporting nanoparticles across the blood-brain barrier
Tian-Tian Zhang et al.
BIOMATERIALS SCIENCE (2016)
Engineering the surface properties of a human monoclonal antibody prevents self-association and rapid clearance in vivo
Claire L. Dobson et al.
SCIENTIFIC REPORTS (2016)
The Current and Future Treatment of Brain Metastases
Douglas A. Hardesty et al.
FRONTIERS IN SURGERY (2016)
Cell-penetrating peptides: Possible transduction mechanisms and therapeutic applications
Zhengrong Guo et al.
BIOMEDICAL REPORTS (2016)
Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking
Pawan Kumar Pandey et al.
TISSUE BARRIERS (2016)
FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin
Michal Pyzik et al.
JOURNAL OF IMMUNOLOGY (2015)
Targeted Therapy for Brain Metastases in EGFR-Mutated and ALK-Rearranged Non-Small-Cell Lung Cancer
Christina S. Baik et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases
Vashti Irani et al.
MOLECULAR IMMUNOLOGY (2015)
Anatomy and physiology of the blood-brain barrier
Yonatan Serlin et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
The Blood-Brain Barrier
Richard Daneman et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)
dNP2 is a blood-brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis
Sangho Lim et al.
NATURE COMMUNICATIONS (2015)
ANG4043, a Novel Brain-Penetrant Peptide-mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice
Anthony Regina et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo
Sofie Stalmans et al.
PLOS ONE (2015)
Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer
Iason T. Papademetriou et al.
THERAPEUTIC DELIVERY (2015)
Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants
Nga Bien-Ly et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
The blood-brain barrier: Structure, function and therapeutic approaches to cross it
Marta Tajes et al.
MOLECULAR MEMBRANE BIOLOGY (2014)
Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies
Joana A. Loureiro et al.
NANOMEDICINE (2014)
Stereotactic radiosurgery (SRS) for brain metastases: a systematic review
Carsten Nieder et al.
RADIATION ONCOLOGY (2014)
Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
Y. Joy Yu et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Cell-Penetrating Peptide-Mediated Therapeutic Molecule Delivery into the Central Nervous System
Li-Li Zou et al.
CURRENT NEUROPHARMACOLOGY (2013)
Physiology of Blood-Brain Interfaces in Relation to Brain Disposition of Small Compounds and Macromolecules
N. Strazielle et al.
MOLECULAR PHARMACEUTICS (2013)
Drug transport across the blood-brain barrier
William M. Pardridge
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Monoclonal antibodies for the treatment of cancer
Casey W. Shuptrine et al.
SEMINARS IN CANCER BIOLOGY (2012)
Epidemiology of Brain Metastases
Lakshmi Nayak et al.
CURRENT ONCOLOGY REPORTS (2012)
Receptor-Mediated Abeta Amyloid Antibody Targeting to Alzheimer's Disease Mouse Brain
Qing-Hui Zhou et al.
MOLECULAR PHARMACEUTICS (2011)
Initial steps of metastasis: Cell invasion and endothelial transmigration
Franziska van Zijl et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2011)
Computational studies of protegrin antimicrobial peptides: A review
Dan S. Bolintineanu et al.
PEPTIDES (2011)
Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target
Y. Joy Yu et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
CYP-Mediated Therapeutic Protein-Drug Interactions Clinical Findings, Proposed Mechanisms and Regulatory Implications
Jang-Ik Lee et al.
CLINICAL PHARMACOKINETICS (2010)
Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases
Reinhard Gabathuler
NEUROBIOLOGY OF DISEASE (2010)
Monoclonal antibodies: versatile platforms for cancer immunotherapy
Louis M. Weiner et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Cell Permeable Peptides: A Promising Tool to Deliver Neuroprotective Agents in the Brain
Xanthi Antoniou et al.
PHARMACEUTICALS (2010)
Therapeutic antibodies: successes, limitations and hopes for the future
Patrick Chames et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Engineered therapeutic antibodies with improved effector functions
Tsuguo Kubota et al.
CANCER SCIENCE (2009)
Chemoattractant Signaling between Tumor Cells and Macrophages Regulates Cancer Cell Migration, Metastasis and Neovascularization
Chad E. Green et al.
PLOS ONE (2009)
Review: Natalizumab in the treatment of multiple sclerosis
Özgür Yaldizli et al.
Therapeutic Advances in Neurological Disorders (2009)
CNS Delivery Via Adsorptive Transcytosis
Francoise Herve et al.
AAPS JOURNAL (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Progress in drug delivery to the central nervous system by the prodrug approach
Barbara Pavan et al.
MOLECULES (2008)
Identification and design of peptides as a new drug delivery system for the brain
Michel Demeule et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Multidisciplinary management of brain Metastases
April F. Eichler et al.
ONCOLOGIST (2007)
A comprehensive model for the cellular uptake of cationic cell-penetrating peptides
Falk Duchardt et al.
TRAFFIC (2007)
Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis
David Fortin et al.
CANCER (2007)
Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2007)
Pharmacological properties, toxicology and scientific rationale for the use of natalizumab (Tysabri (R)) in inflammatory diseases
Olaf Stueve et al.
CNS DRUG REVIEWS (2007)
Blood-brain barrier delivery
William M. Pardridge
DRUG DISCOVERY TODAY (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Blood-brain barrier targeting of BDNF improves motor function in rats with middle cerebral artery occlusion
Yun Zhang et al.
BRAIN RESEARCH (2006)
Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound
M Kinoshita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling
T Ben-Zvi et al.
JOURNAL OF CELL SCIENCE (2006)
Breast cancer metastasis to the central nervous system
RJ Weil et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Targeted therapy for brain tumours
MS Lesniak et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport
CV Borlongan et al.
BRAIN RESEARCH BULLETIN (2003)
Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability
KA Witt et al.
PEPTIDES (2001)
Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor
MJ Coloma et al.
PHARMACEUTICAL RESEARCH (2000)
Share Paper
